These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36854810)

  • 1. The effect of autosomal dominant polycystic kidney disease on mucociliary clearance.
    Kara İ; Öztürk İ; Doğaner A; Yıldız MG; Güzel FB; Kılıç A; Orhan İ; Altınören O
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2359-2364. PubMed ID: 36854810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing.
    Alzahrani OR; Alatwi HE; Alharbi AA; Alessa AH; Al-Amer OM; Alanazi AFR; Shams AM; Alomari E; Naser AY; Alzahrani FA; Hosawi S; Alghamdi SM; Abdali WA; Elfaki I; Hawsawi YM
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.
    Magistroni R; He N; Wang K; Andrew R; Johnson A; Gabow P; Dicks E; Parfrey P; Torra R; San-Millan JL; Coto E; Van Dijk M; Breuning M; Peters D; Bogdanova N; Ligabue G; Albertazzi A; Hateboer N; Demetriou K; Pierides A; Deltas C; St George-Hyslop P; Ravine D; Pei Y
    J Am Soc Nephrol; 2003 May; 14(5):1164-74. PubMed ID: 12707387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease.
    Kurashige M; Hanaoka K; Imamura M; Udagawa T; Kawaguchi Y; Hasegawa T; Hosoya T; Yokoo T; Maeda S
    Clin Genet; 2015 Mar; 87(3):266-72. PubMed ID: 24611717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of nasal mucociliary activity in patients with Behçet's disease.
    Ozbay I; Kucur C; Temİzturk F; Ozkan Y; Kahraman C; Oghan F
    J Laryngol Otol; 2016 Apr; 130(4):348-51. PubMed ID: 26841706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.
    Tan AY; Zhang T; Michaeel A; Blumenfeld J; Liu G; Zhang W; Zhang Z; Zhu Y; Rennert L; Martin C; Xiang J; Salvatore SP; Robinson BD; Kapur S; Donahue S; Bobb WO; Rennert H
    J Am Soc Nephrol; 2018 Aug; 29(8):2139-2156. PubMed ID: 30042192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nasal mucociliary clearance using saccharin test in smokers: A prospective study.
    Dülger S; Akdeniz Ö; Solmaz F; Şengören Dikiş Ö; Yildiz T
    Clin Respir J; 2018 Apr; 12(4):1706-1710. PubMed ID: 29105352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients.
    Torra R; Badenas C; Pérez-Oller L; Luis J; Millán S; Nicolau C; Oppenheimer F; Milà M; Darnell A
    Am J Kidney Dis; 2000 Oct; 36(4):728-34. PubMed ID: 11007674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior rhinomanometry and determination of nasal mucociliary clearance time with the saccharin test in children with Crimean-Congo hemorrhagic fever.
    Altuntaş EE; Kaya A; Uysal IÖ; Cevit Ö; Içağasioğlu D; Müderris S
    J Craniofac Surg; 2013 May; 24(3):e239-42. PubMed ID: 23714976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
    Sekine A; Hoshino J; Fujimaru T; Suwabe T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
    Am J Nephrol; 2020; 51(9):745-751. PubMed ID: 32784291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Mutations in the PKD1 and PKD2 Genes of Chinese Patients with Autosomal Dominant Polycystic Kidney Disease.
    Xu D; Ma Y; Gu X; Bian R; Lu Y; Xing X; Mei C
    Kidney Blood Press Res; 2018; 43(2):297-309. PubMed ID: 29529603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between nasal mucociliary clearance time and the degree of smoking dependence in smokers with obstructive sleep apnea syndrome.
    Dülger S; Çapkur Ç; Gençay S; Özmen S; Solmaz F; Şengören Dikiş Ö; Yıldız T
    Adv Respir Med; 2021; 89(4):353-358. PubMed ID: 34269400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.
    Zhang W; Stephens CJ; Blumenfeld JD; Behzadi AH; Donahue S; Bobb WO; Newhouse JH; Rennert H; Zhao Y; Prince MR
    J Magn Reson Imaging; 2019 Mar; 49(3):894-903. PubMed ID: 30230107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
    Moriyama T; Nakayama Y; Soejima M; Yokota Y; Ota K; Ito S; Kodama G; Nakamura N; Kurokawa Y; Yano J; Ueda U; Takamiya Y; Kaida Y; Hazama T; Shibata R; Koda Y; Fukami K
    Clin Exp Nephrol; 2021 Mar; 25(3):251-260. PubMed ID: 33141305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.
    Audrézet MP; Corbiere C; Lebbah S; Morinière V; Broux F; Louillet F; Fischbach M; Zaloszyc A; Cloarec S; Merieau E; Baudouin V; Deschênes G; Roussey G; Maestri S; Visconti C; Boyer O; Abel C; Lahoche A; Randrianaivo H; Bessenay L; Mekahli D; Ouertani I; Decramer S; Ryckenwaert A; Cornec-Le Gall E; Salomon R; Ferec C; Heidet L
    J Am Soc Nephrol; 2016 Mar; 27(3):722-9. PubMed ID: 26139440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
    Shigemori K; Higashihara E; Itoh M; Yoshida H; Yamamoto K; Nutahara K; Shiokawa Y; Kaname S; Tambo M; Yamaguchi T; Taguchi S; Yoshioka T; Yokoyama K; Fukuhara H
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105943. PubMed ID: 34175641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.